ESR1 and Familial prostate cancer: These compounds may serve not only as tools for deciphering the biological functions of the ERα/β heterodimer, but also potentially as a means for therapeutically targeting ERα/β heterodimers in hormone-dependent diseases including breast and prostate cancers.